Skip to main content
Top
Published in: Journal of Gastroenterology 5/2014

Open Access 01-05-2014 | Original Article—Alimentary Tract

Prevalence of serum celiac antibody in patients with IBD in Japan

Authors: Chikako Watanabe, Shunsuke Komoto, Ryota Hokari, Chie Kurihara, Yoshikiyo Okada, Hideaki Hozumi, Masaaki Higashiyama, Atsushi Sakuraba, Kengo Tomita, Yoshikazu Tsuzuki, Atsushi Kawaguchi, Shigeaki Nagao, Sho Ogata, Soichiro Miura

Published in: Journal of Gastroenterology | Issue 5/2014

Login to get access

Abstract

Background

Although the incidence of inflammatory bowel diseases (IBD) in Japan has increased, the prevalence of celiac disease is considered very low with the lowest genetic disposition. IBD is reported as the most common comorbidity because of the high positive rate of serological celiac markers. The aim of this study was to examine the current incidence of celiac disease, especially in IBD patients in Japan, where both wheat consumption and incidence of IBD have increased.

Methods

A total of 172 patients with IBD and 190 controls in Japan were screened for serum antibody of tissue transglutaminase and deaminated gliadin peptide. In sero-positive patients, HLA testing and upper gastrointestinal endoscopy with duodenal biopsy was performed. Some of the sero-positive patients started a gluten-restricted or unrestricted diet, and serological change was determined.

Results

The positivity of both serum antibodies was significantly higher in IBD and correlated with disease activity. However, no biopsy-defined or HLA-defined true celiac disease was found. A decrease in serum antibody titers was observed with a gluten-restricted diet.

Conclusions

Despite the increased incidence of IBD and high positivity for serum celiac antibody in Japanese IBD patients, no true-positive celiac disease was noted, suggesting the presence of gluten intolerance in these populations.
Literature
1.
go back to reference Freeman HJ. Biopsy-defined adult celiac disease in Asian-Canadians. Can J Gastroenterol. 2003;17:433–6.PubMed Freeman HJ. Biopsy-defined adult celiac disease in Asian-Canadians. Can J Gastroenterol. 2003;17:433–6.PubMed
2.
go back to reference Makishima H, Komiyama Y, Asano N, Momose K, Nakamura S, Ishida F. Peripheral T-cell lymphoma following diffuse large B-cell lymphoma associated with celiac disease. Intern Med. 2008;47:295–8.PubMedCrossRef Makishima H, Komiyama Y, Asano N, Momose K, Nakamura S, Ishida F. Peripheral T-cell lymphoma following diffuse large B-cell lymphoma associated with celiac disease. Intern Med. 2008;47:295–8.PubMedCrossRef
3.
go back to reference Shaoul R, Marcon MA, Okada Y, Cutz E, Forstner G. Gastric metaplasia: a frequently overlooked feature of duodenal biopsy specimens in untreated celiac disease. J Pediatr Gastroenterol Nutr. 2000;30:397–403.PubMedCrossRef Shaoul R, Marcon MA, Okada Y, Cutz E, Forstner G. Gastric metaplasia: a frequently overlooked feature of duodenal biopsy specimens in untreated celiac disease. J Pediatr Gastroenterol Nutr. 2000;30:397–403.PubMedCrossRef
4.
go back to reference Di Tola M, Sabbatella L, Anania MC, Viscido A, Caprilli R, Pica R, et al. Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin Chem Lab Med. 2004;42:1092–7.PubMedCrossRef Di Tola M, Sabbatella L, Anania MC, Viscido A, Caprilli R, Pica R, et al. Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin Chem Lab Med. 2004;42:1092–7.PubMedCrossRef
5.
go back to reference Bizzaro N, Villalta D, Tonutti E, Doria A, Tampoia M, Bassetti D, et al. IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Dig Dis Sci. 2003;48:2360–5.PubMedCrossRef Bizzaro N, Villalta D, Tonutti E, Doria A, Tampoia M, Bassetti D, et al. IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Dig Dis Sci. 2003;48:2360–5.PubMedCrossRef
6.
go back to reference Sblattero D, Berti I, Trevisiol C, Marzari R, Tommasini A, Bradbury A, et al. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol. 2000;95:1253–7.PubMedCrossRef Sblattero D, Berti I, Trevisiol C, Marzari R, Tommasini A, Bradbury A, et al. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol. 2000;95:1253–7.PubMedCrossRef
7.
go back to reference D’Argenio G, Biancone L, Cosenza V, Della Valle N, D’Armiento FP, Boirivant M, et al. Transglutaminases in Crohn’s disease. Gut. 1995;37:690–5.PubMedCentralPubMedCrossRef D’Argenio G, Biancone L, Cosenza V, Della Valle N, D’Armiento FP, Boirivant M, et al. Transglutaminases in Crohn’s disease. Gut. 1995;37:690–5.PubMedCentralPubMedCrossRef
8.
go back to reference Carroccio A, Giannitrapani L, Soresi M, Not T, Iacono G, Di Rosa C, et al. Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease. Gut. 2001;49:506–11.PubMedCentralPubMedCrossRef Carroccio A, Giannitrapani L, Soresi M, Not T, Iacono G, Di Rosa C, et al. Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease. Gut. 2001;49:506–11.PubMedCentralPubMedCrossRef
9.
go back to reference Clemente MG, Frau F, Musu MP, De Virgilis S. Antibodies to tissue transglutaminase outside celiac disease. Ital J Gastroenterol Hepatol. 1999;6:546. Clemente MG, Frau F, Musu MP, De Virgilis S. Antibodies to tissue transglutaminase outside celiac disease. Ital J Gastroenterol Hepatol. 1999;6:546.
10.
go back to reference Leon F, Camarero C, R-Pena R, Eiras P, Sanchez L, Baragaño M, et al. Anti-transglutaminase IgA ELISA: clinical potential and drawbacks in celiac disease diagnosis. Scand J Gastroenterol. 2001;36:849–53.PubMedCrossRef Leon F, Camarero C, R-Pena R, Eiras P, Sanchez L, Baragaño M, et al. Anti-transglutaminase IgA ELISA: clinical potential and drawbacks in celiac disease diagnosis. Scand J Gastroenterol. 2001;36:849–53.PubMedCrossRef
11.
go back to reference Schuffler MD, Chaffee RG. Small intestinal biopsy in a patient with Crohn’s disease of the duodenum. The spectrum of abnormal findings in the absence of granulomas. Gastroenterology. 1979;76:1009–14.PubMed Schuffler MD, Chaffee RG. Small intestinal biopsy in a patient with Crohn’s disease of the duodenum. The spectrum of abnormal findings in the absence of granulomas. Gastroenterology. 1979;76:1009–14.PubMed
12.
go back to reference Rostami K, Kerckhaert J, Tiemessen R. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol. 1999;94:888–94.PubMedCrossRef Rostami K, Kerckhaert J, Tiemessen R. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol. 1999;94:888–94.PubMedCrossRef
13.
go back to reference Abrams JA, Diamond B, Rotterdam H, Green PH. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci. 2004;49:546–50.PubMedCrossRef Abrams JA, Diamond B, Rotterdam H, Green PH. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci. 2004;49:546–50.PubMedCrossRef
14.
go back to reference Schwertz E, Kahlenberg F, Sack U, Richter T, Stern M, Conrad K, et al. Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin Chem. 2004;50:2370–5.PubMedCrossRef Schwertz E, Kahlenberg F, Sack U, Richter T, Stern M, Conrad K, et al. Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin Chem. 2004;50:2370–5.PubMedCrossRef
15.
go back to reference Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology. 2009;137:1912–33.PubMedCrossRef Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology. 2009;137:1912–33.PubMedCrossRef
16.
go back to reference Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–60.PubMedCrossRef Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–60.PubMedCrossRef
17.
go back to reference Kurppa K, Lindfors K, Collin P, Saavalainen P, Partanen J, Haimila K, et al. Antibodies against deamidated gliadin peptides in early-stage celiac disease. J Clin Gastroenterol. 2011;45:673–8.PubMedCrossRef Kurppa K, Lindfors K, Collin P, Saavalainen P, Partanen J, Haimila K, et al. Antibodies against deamidated gliadin peptides in early-stage celiac disease. J Clin Gastroenterol. 2011;45:673–8.PubMedCrossRef
18.
go back to reference Monzani A, Rapa A, Fonio P, Tognato E, Panigati L, Oderda G. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease. J Pediatr Gastroenterol Nutr. 2011;53:55–60.PubMedCrossRef Monzani A, Rapa A, Fonio P, Tognato E, Panigati L, Oderda G. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease. J Pediatr Gastroenterol Nutr. 2011;53:55–60.PubMedCrossRef
19.
go back to reference Mäki M, Holm K, Lipsanen V, Hällström O, Viander M, Collin P, et al. Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease. Lancet. 1991;338:1350–3.PubMedCrossRef Mäki M, Holm K, Lipsanen V, Hällström O, Viander M, Collin P, et al. Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease. Lancet. 1991;338:1350–3.PubMedCrossRef
20.
21.
go back to reference Paparo F, Petrone E, Tosco A, Maglio M, Borrelli M, Salvati VM, et al. Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. Am J Gastroenterol. 2005;100:2294–8.PubMedCrossRef Paparo F, Petrone E, Tosco A, Maglio M, Borrelli M, Salvati VM, et al. Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. Am J Gastroenterol. 2005;100:2294–8.PubMedCrossRef
22.
23.
24.
go back to reference Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625–9.PubMedCrossRef Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625–9.PubMedCrossRef
25.
26.
go back to reference van der Windt DA, Jellema P, Mulder CJ, Kneepkens CM, van der Horst HE. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010;303:1738–46.PubMedCrossRef van der Windt DA, Jellema P, Mulder CJ, Kneepkens CM, van der Horst HE. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010;303:1738–46.PubMedCrossRef
27.
go back to reference Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, McMillan S, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med. 2010;42:587–95.PubMedCrossRef Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, McMillan S, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med. 2010;42:587–95.PubMedCrossRef
28.
go back to reference Barada K, Bitar A, Mokadem MA, Hashash JG, Green P. Celiac disease in Middle Eastern and North African countries: a new burden? World J Gastroenterol. 2010;16:1449–57.PubMedCentralPubMedCrossRef Barada K, Bitar A, Mokadem MA, Hashash JG, Green P. Celiac disease in Middle Eastern and North African countries: a new burden? World J Gastroenterol. 2010;16:1449–57.PubMedCentralPubMedCrossRef
29.
go back to reference Bizzaro N, Villalta D, Tonutti E, Doria A, Tampoia M, Bassetti D, et al. IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Dig Dis Sci. 2003;48:2360–5.PubMedCrossRef Bizzaro N, Villalta D, Tonutti E, Doria A, Tampoia M, Bassetti D, et al. IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Dig Dis Sci. 2003;48:2360–5.PubMedCrossRef
30.
go back to reference Ribeiro-Cabral VL, da-Silva-Patrício FR, Ambrogini-Junior O, Jankiel-Miszputen S. Anti-tissue transglutaminase antibodies (IgA and IgG) in both Crohn’s disease and autoimmune diabetes. Rev Esp Enferm Dig. 2011;103:453–7.PubMedCrossRef Ribeiro-Cabral VL, da-Silva-Patrício FR, Ambrogini-Junior O, Jankiel-Miszputen S. Anti-tissue transglutaminase antibodies (IgA and IgG) in both Crohn’s disease and autoimmune diabetes. Rev Esp Enferm Dig. 2011;103:453–7.PubMedCrossRef
31.
go back to reference Tavakkoli H, Haghdani S, Adilipour H, Daghaghzadeh H, Minakari M, Adibi P, et al. Serologic celiac disease in patients with inflammatory bowel disease. J Res Med Sci. 2012;17:154–8.PubMedCentralPubMed Tavakkoli H, Haghdani S, Adilipour H, Daghaghzadeh H, Minakari M, Adibi P, et al. Serologic celiac disease in patients with inflammatory bowel disease. J Res Med Sci. 2012;17:154–8.PubMedCentralPubMed
32.
go back to reference Ludvigsson JF, Brandt L, Montgomery SM, Granath F, Ekbom A. Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers. BMC Gastroenterology. 2009;9:19.PubMedCentralPubMedCrossRef Ludvigsson JF, Brandt L, Montgomery SM, Granath F, Ekbom A. Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers. BMC Gastroenterology. 2009;9:19.PubMedCentralPubMedCrossRef
33.
go back to reference Wright CL, Riddell RH. Histology of the stomach and duodenum in Crohn’s disease. Am J Surg Pathol. 1998;22:383–90.PubMedCrossRef Wright CL, Riddell RH. Histology of the stomach and duodenum in Crohn’s disease. Am J Surg Pathol. 1998;22:383–90.PubMedCrossRef
34.
go back to reference Yang A, Chen Y, Scherl E. Inflammatory bowel disease in patients with celiac disease. Inflamm Bowel Dis. 2005;11:528–32.PubMedCrossRef Yang A, Chen Y, Scherl E. Inflammatory bowel disease in patients with celiac disease. Inflamm Bowel Dis. 2005;11:528–32.PubMedCrossRef
35.
go back to reference Karell K, Louka AS, Moodie SJ. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol. 2003;64:469–77.PubMedCrossRef Karell K, Louka AS, Moodie SJ. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol. 2003;64:469–77.PubMedCrossRef
36.
go back to reference Liu E, Li M, Emery L, Taki I, Barriga K, Tiberti C, et al. Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease. J Pediatr Gastroenterol Nutr. 2007;45:293–300.PubMedCrossRef Liu E, Li M, Emery L, Taki I, Barriga K, Tiberti C, et al. Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease. J Pediatr Gastroenterol Nutr. 2007;45:293–300.PubMedCrossRef
37.
go back to reference Farrace MG, Picarelli A, Di Tola M, Sabbatella L, Marchione OP, Ippolito G, et al. Presence of anti-“tissue” transglutaminase antibodies in inflammatory intestinal diseases: an apoptosis-associated event? Cell Death Differ. 2001;8:767–70.PubMedCrossRef Farrace MG, Picarelli A, Di Tola M, Sabbatella L, Marchione OP, Ippolito G, et al. Presence of anti-“tissue” transglutaminase antibodies in inflammatory intestinal diseases: an apoptosis-associated event? Cell Death Differ. 2001;8:767–70.PubMedCrossRef
38.
go back to reference Söderholm JD, Olaison G, Peterson KH, Franzén LE, Lindmark T, Wirén M, et al. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn’s disease. Gut. 2002;50:307–13.PubMedCentralPubMedCrossRef Söderholm JD, Olaison G, Peterson KH, Franzén LE, Lindmark T, Wirén M, et al. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn’s disease. Gut. 2002;50:307–13.PubMedCentralPubMedCrossRef
39.
go back to reference Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology. 1999;116:301–9.PubMedCrossRef Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology. 1999;116:301–9.PubMedCrossRef
40.
go back to reference Schürmann G, Brüwer M, Klotz A, Schmid KW, Senninger N, Zimmer KP. Transepithelial transport processes at the intestinal mucosa in inflammatory bowel disease. Int J Colorectal Dis. 1999;14:41–6.PubMedCrossRef Schürmann G, Brüwer M, Klotz A, Schmid KW, Senninger N, Zimmer KP. Transepithelial transport processes at the intestinal mucosa in inflammatory bowel disease. Int J Colorectal Dis. 1999;14:41–6.PubMedCrossRef
41.
go back to reference Sander GR, Cummins AG, Henshall T, Powell BC. Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBBS Lett. 2005;579:4851–5.CrossRef Sander GR, Cummins AG, Henshall T, Powell BC. Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBBS Lett. 2005;579:4851–5.CrossRef
42.
go back to reference Elli L, Dolfini E, Bardella MT. Gliadin cytotoxicity and in vitro cell cultures. Toxicol Lett. 2003;146:1–8.PubMedCrossRef Elli L, Dolfini E, Bardella MT. Gliadin cytotoxicity and in vitro cell cultures. Toxicol Lett. 2003;146:1–8.PubMedCrossRef
43.
go back to reference Hadjivassiliou M, Williamson CA, Woodroofe N. The immunology of gluten sensitivity: beyond the gut. Trend Immunol. 2004;25:578–82.CrossRef Hadjivassiliou M, Williamson CA, Woodroofe N. The immunology of gluten sensitivity: beyond the gut. Trend Immunol. 2004;25:578–82.CrossRef
44.
go back to reference Bentz S, Hausmann M, Piberger H, Kellermeier S, Paul S, Held L, et al. Clinical relevance of IgG antibodies against food antigens in Crohn’s disease: a double-blind cross-over diet intervention study. Digestion. 2010;81:252–64.PubMedCrossRef Bentz S, Hausmann M, Piberger H, Kellermeier S, Paul S, Held L, et al. Clinical relevance of IgG antibodies against food antigens in Crohn’s disease: a double-blind cross-over diet intervention study. Digestion. 2010;81:252–64.PubMedCrossRef
45.
go back to reference Tosco A, Salvati VM, Auricchio R, Maglio M, Borrelli M, Coruzzo A, et al. Natural history of potential celiac disease in children. Clin Gastroenterol Hepatol. 2011;9:320–5.PubMedCrossRef Tosco A, Salvati VM, Auricchio R, Maglio M, Borrelli M, Coruzzo A, et al. Natural history of potential celiac disease in children. Clin Gastroenterol Hepatol. 2011;9:320–5.PubMedCrossRef
46.
go back to reference Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn’s disease. Gastroenterology. 2002;123:86–91.PubMedCrossRef Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn’s disease. Gastroenterology. 2002;123:86–91.PubMedCrossRef
47.
go back to reference Makharia GK, Verma AK, Amarchand R, Bhatnagar S, Das P, Goswami A, et al. Prevalence of celiac disease in the northern part of India: a community based study. J Gastroenterol Hepatol. 2011;26:894–900.PubMedCrossRef Makharia GK, Verma AK, Amarchand R, Bhatnagar S, Das P, Goswami A, et al. Prevalence of celiac disease in the northern part of India: a community based study. J Gastroenterol Hepatol. 2011;26:894–900.PubMedCrossRef
Metadata
Title
Prevalence of serum celiac antibody in patients with IBD in Japan
Authors
Chikako Watanabe
Shunsuke Komoto
Ryota Hokari
Chie Kurihara
Yoshikiyo Okada
Hideaki Hozumi
Masaaki Higashiyama
Atsushi Sakuraba
Kengo Tomita
Yoshikazu Tsuzuki
Atsushi Kawaguchi
Shigeaki Nagao
Sho Ogata
Soichiro Miura
Publication date
01-05-2014
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 5/2014
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-013-0838-6

Other articles of this Issue 5/2014

Journal of Gastroenterology 5/2014 Go to the issue